TipRanks
Oric Pharmaceuticals (DE:4TZ)
FRANKFURT:4TZ

Compare Oric Pharmaceuticals (4TZ) vs. Competitors

1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Oric Pharmaceuticals
€11.35
€1.11B
-8.87
-13.93%
9 Buy
0 Hold
0 Sell
Strong Buy
CytomX Therapeutics
$3.37
$560.00M
-5.66
-25.51%
4 Buy
0 Hold
0 Sell
Strong Buy
AnaptysBio
$58.00
$1.37B
6.81
44.63%
7 Buy
0 Hold
0 Sell
Strong Buy
Cullinan Management
$22.60
$999.43M
-4.58
120.28%
12 Buy
0 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$24.73
$1.16B
-5.64
-4.16%
7 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:4TZ
Oric Pharmaceuticals
10.50
-1.10
-9.48%
CTMX
CytomX Therapeutics
2.57
-0.83
-24.41%
ANAB
AnaptysBio
45.95
24.31
112.38%
CGEM
Cullinan Management
15.53
7.70
98.34%
BCAX
Bicara Therapeutics Inc.
17.50
-1.01
-5.46%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts